Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Sales | 462 | 0 | 0 |
| Gross Profit | 462 | N/A | N/A |
| Operating Expenses | 17,006 | 0 | 0 |
| Operating Income | -16,544 | N/A | N/A |
| Interest Expense | 124 | 0 | 0 |
| Pre-tax Income | -16,668 | 0 | 0 |
| Income Tax | 35 | N/A | N/A |
| Net Income Continuous | -16,703 | N/A | N/A |
| Minority Interests | -16,703 | N/A | N/A |
| Net Income | $N/A | $N/A | $N/A |
| EBITDA(a) | $-15,955 | $N/A | $N/A |